Altium Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-315,070
| Closed | -$1.13M | – | 115 |
|
|
2022
Q4 | $1.13M | Buy |
+315,070
| New | +$1.13M | 0.57% | 41 |
|
|
2022
Q1 | – | Sell |
-116,000
| Closed | -$3.78M | – | 153 |
|
|
2021
Q4 | $3.78M | Sell |
116,000
-11,241
| -9% | -$366K | 1.04% | 36 |
|
|
2021
Q3 | $5.69M | Buy |
127,241
+19,547
| +18% | +$874K | 1.49% | 19 |
|
|
2021
Q2 | $5.87M | Buy |
107,694
+95,024
| +750% | +$5.18M | 1.36% | 18 |
|
|
2021
Q1 | $948K | Buy |
+12,670
| New | +$948K | 0.26% | 111 |
|